Skip to main content
Year archive

Karo Pharma AB — 2021 filings

All 26 regulatory filings released by Karo Pharma AB (KARO) in 2021, sourced directly from the official regulator.

26 Filings
2021 Period
2021 filings (26)
Filing Released Lang
Karo Pharma enters into an agreement for the potential acquisition of the E45® brand from Reckitt
M&A Activity
2021-12-24 English
Karo Pharma ingår avtal med avsikt att förvärva E45® från Reckitt
M&A Activity
2021-12-24 Swedish
Karo Pharma avser att byta lista till Nasdaq First North Growth Market under första halvåret 2022
Delisting Announcement
2021-12-15 Swedish
Karo Pharma intends to change listing venue to Nasdaq First North Growth Market during the first half of 2022
Delisting Announcement
2021-12-15 English
Karo Pharma förvärvar Sylphar International NV för 290 MEUR och avser genomföra en företrädesemission om cirka 200-250 MEUR
Capital/Financing Update
2021-11-23 Swedish
Karo Pharma acquires Sylphar International NV for EUR 290m and intends to carry out a rights issue of approximately EUR 200-250m
M&A Activity
2021-11-23 English
Anna Hale utsedd till CMO på Karo Pharma
Board/Management Information
2021-09-07 Swedish
Anna Hale appointed CMO at Karo Pharma
Board/Management Information
2021-09-07 English
Magnus Nylén leaves Karo Pharma, Matt Roberts appointed new CCO
Board/Management Information
2021-08-24 English
Magnus Nylén lämnar Karo Pharma, Matt Roberts utsedd till ny CCO
Board/Management Information
2021-08-24 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report Q2 2021
2021-07-22 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report Q2 2021
2021-07-22 English
Karo Pharma to sell its treasury shares
Transaction in Own Shares
2021-05-06 English
Karo Pharma säljer egna aktier
Transaction in Own Shares
2021-05-06 Swedish
Karo Pharma beslutar om försäljning av egna aktier
Transaction in Own Shares
2021-04-28 Swedish
Karo Pharma resolves on sale of own shares
Transaction in Own Shares
2021-04-28 English
ÅRSSTÄMMA 2021 i KARO PHARMA AKTIEBOLAG
AGM Information
2021-04-21 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report Q1 2021
2021-04-21 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report Q1 2021
2021-04-21 English
Report Publication Announcement 2021
Report Publication Announcement
2021-03-30 Swedish
Report Publication Announcement 2021
Report Publication Announcement
2021-03-30 English
Kallelse till Årsstämma i Karo Pharma Aktiebolag
AGM Information
2021-03-19 Swedish
Earnings Release 2020
Earnings Release Q4 2020
2021-02-18 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report FY 2020
2021-02-18 English
Karo Pharma förvärvar europeisk varumärkesportfölj från Teva Pharmaceuticals
M&A Activity
2021-02-03 Swedish
Karo Pharma acquires European OTC brand portfolio from Teva Pharmaceuticals
Regulatory Filings
2021-02-03 English